Effectiveness, safety, and health-related quality of life outcomes in patients with hemophilia A receiving antihemophilic factor (recombinant) in a real-world setting: results of a 6-year interim analysis of the AHEAD International study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Haemophilia Année : 2020

Effectiveness, safety, and health-related quality of life outcomes in patients with hemophilia A receiving antihemophilic factor (recombinant) in a real-world setting: results of a 6-year interim analysis of the AHEAD International study

Fichier non déposé

Dates et versions

hal-02881476 , version 1 (25-06-2020)

Identifiants

  • HAL Id : hal-02881476 , version 1

Citer

Johannes Oldenburg, Margareth C. Ozelo, Robert Klamroth, Benoît Guillet, Kate Khair, et al.. Effectiveness, safety, and health-related quality of life outcomes in patients with hemophilia A receiving antihemophilic factor (recombinant) in a real-world setting: results of a 6-year interim analysis of the AHEAD International study. Haemophilia, 2020, 26, pp.95-96. ⟨hal-02881476⟩
26 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More